113 related articles for article (PubMed ID: 38917957)
1. Injectable nano-in situ-thermosensitive-hydrogels based on halofuginone and silver for postoperative treatment against triple-negative breast cancer.
Zuo R; Gong J; Gao X; Nepovimova E; Zhang J; Jiang S; Kuca K; Wu W; Guo D
Int J Pharm; 2024 Jun; ():124384. PubMed ID: 38917957
[TBL] [Abstract][Full Text] [Related]
2. Using halofuginone-silver thermosensitive nanohydrogels with antibacterial and anti-inflammatory properties for healing wounds infected with Staphylococcus aureus.
Zuo RN; Gong JH; Gao XG; Huang JH; Zhang JR; Jiang SX; Guo DW
Life Sci; 2024 Feb; 339():122414. PubMed ID: 38216121
[TBL] [Abstract][Full Text] [Related]
3. Halofuginone-guided nano-local therapy: Nano-thermosensitive hydrogels for postoperative metastatic canine mammary carcinoma with scar removal.
Zuo R; Kong L; Pang W; Jiang S
Int J Pharm X; 2024 Jun; 7():100241. PubMed ID: 38572023
[TBL] [Abstract][Full Text] [Related]
4. Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis.
Zuo R; Zhang Y; Chen X; Hu S; Song X; Gao X; Gong J; Ji H; Yang F; Peng L; Fang K; Lv Y; Zhang J; Jiang S; Guo D
Int J Nanomedicine; 2022; 17():2475-2491. PubMed ID: 35668999
[TBL] [Abstract][Full Text] [Related]
5. Photo-responsive hydrogel facilitates nutrition deprivation by an ambidextrous approach for preventing cancer recurrence and metastasis.
Wang H; Jin Y; Tan Y; Zhu H; Huo W; Niu P; Li Z; Zhang J; Liang XJ; Yang X
Biomaterials; 2021 Aug; 275():120992. PubMed ID: 34218050
[TBL] [Abstract][Full Text] [Related]
6. Combined chemotherapy for triple negative breast cancer treatment by paclitaxel and niclosamide nanocrystals loaded thermosensitive hydrogel.
Zhao D; Hu C; Fu Q; Lv H
Eur J Pharm Sci; 2021 Dec; 167():105992. PubMed ID: 34517104
[TBL] [Abstract][Full Text] [Related]
7. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
[TBL] [Abstract][Full Text] [Related]
8. Systemic platelet inhibition with localized chemotherapy by an injectable ROS-scavenging gel against postsurgical breast cancer recurrence and metastasis.
Gui J; Zhu Y; Chen X; Gong T; Zhang Z; Yu R; Fu Y
Acta Biomater; 2024 Mar; 177():388-399. PubMed ID: 38307476
[TBL] [Abstract][Full Text] [Related]
9. Two Sides to the Same Coin-Cytotoxicity vs. Potential Metastatic Activity of AgNPs Relative to Triple-Negative Human Breast Cancer MDA-MB-436 Cells.
Matysiak-Kucharek M; Czajka M; Jodłowska-Jędrych B; Sawicki K; Wojtyła-Buciora P; Kruszewski M; Kapka-Skrzypczak L
Molecules; 2020 May; 25(10):. PubMed ID: 32443890
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.
Shin SU; Cho HM; Das R; Gil-Henn H; Ramakrishnan S; Al Bayati A; Carroll SF; Zhang Y; Sankar AP; Elledge C; Pimentel A; Blonska M; Rosenblatt JD
Cells; 2021 Oct; 10(11):. PubMed ID: 34831127
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-nanocrystals-loaded network thermosensitive hydrogel for localised postsurgical recurrent of breast cancer after surgical resection.
Fan R; Sun W; Zhang T; Wang R; Tian Y; Zhang H; Li J; Zheng A; Song S
Biomed Pharmacother; 2022 Jun; 150():113017. PubMed ID: 35483193
[TBL] [Abstract][Full Text] [Related]
12. Potential use of bio functionalized nanoparticles to attenuate triple negative breast cancer (MDA-MB-231 cells).
Santhoshkumar M; Perumal D; Narenkumar J; Ramachandran V; Muthusamy K; Alfarhan A; David E
Bioprocess Biosyst Eng; 2023 Jun; 46(6):803-811. PubMed ID: 36977929
[TBL] [Abstract][Full Text] [Related]
13. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
[TBL] [Abstract][Full Text] [Related]
14. Injectable anti-cancer drug loaded silk-based hydrogel for the prevention of cancer recurrence and post-lumpectomy tissue regeneration aiding triple-negative breast cancer therapy.
Jaiswal C; Gupta T; Jadi PK; Moses JC; Mandal BB
Biomater Adv; 2023 Feb; 145():213224. PubMed ID: 36516618
[TBL] [Abstract][Full Text] [Related]
15. Pingxiao capsule inhibits lung metastasis of triple-negative breast cancer and sensitizes breast cancer to radiotherapy.
Wenjuan T; Yu HU; Man Z; Mingzhi D; Tieming L; Ammar S; Yingzhuan Z; Yanmin Z
J Tradit Chin Med; 2023 Oct; 43(5):897-905. PubMed ID: 37679977
[TBL] [Abstract][Full Text] [Related]
16. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.
Zhu Y; Tao Z; Chen Y; Lin S; Zhu M; Ji W; Liu X; Li T; Hu X
Breast Cancer Res Treat; 2022 May; 193(1):65-81. PubMed ID: 35254603
[TBL] [Abstract][Full Text] [Related]
17. Thermosensitive injectable in-situ forming carboxymethyl chitin hydrogel for three-dimensional cell culture.
Liu H; Liu J; Qi C; Fang Y; Zhang L; Zhuo R; Jiang X
Acta Biomater; 2016 Apr; 35():228-37. PubMed ID: 26911882
[TBL] [Abstract][Full Text] [Related]
18. Novel fabrication and biological characterizations of AgNPs-decorated PEEK with gelatin functional nanocomposite to improve superior biomedical applications.
Jiang J; You D; Wang Q; Gao G
J Biomater Sci Polym Ed; 2022 Apr; 33(5):590-604. PubMed ID: 34752202
[TBL] [Abstract][Full Text] [Related]
19. Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche.
Xia C; Bai W; Deng T; Li T; Zhang L; Lu Z; Zhang Z; Li M; He Q
Acta Biomater; 2023 Mar; 158():708-724. PubMed ID: 36638937
[TBL] [Abstract][Full Text] [Related]
20. Codelivery of anti-cancer agents via double-walled polymeric microparticles/injectable hydrogel: A promising approach for treatment of triple negative breast cancer.
Davoodi P; Ng WC; Srinivasan MP; Wang CH
Biotechnol Bioeng; 2017 Dec; 114(12):2931-2946. PubMed ID: 28832946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
